Once-weekly somapacitan enhances linear growth in girls with Turner syndrome: a randomized controlled phase 3 study.

Mauras N, Boettcher C, Højby M, Soltysik K, Jorge AAL, Kashimada K, Linglart A, Luo X, Murray PG, Backeljauw P

Open source

DOI
10.1210/clinem/dgag309
Published
2026 Aug 1
Container
The Journal of clinical endocrinology and metabolism
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1210/clinem/dgag309,
  title = {Once-weekly somapacitan enhances linear growth in girls with Turner syndrome: a randomized controlled phase 3 study.},
  author = {Mauras N and Boettcher C and Højby M and Soltysik K and Jorge AAL and Kashimada K and Linglart A and Luo X and Murray PG and Backeljauw P},
  year = {2026},
  journal = {The Journal of clinical endocrinology and metabolism},
  doi = {10.1210/clinem/dgag309},
  url = {https://doi.org/10.1210/clinem/dgag309}
}

RIS

TY  - JOUR
TI  - Once-weekly somapacitan enhances linear growth in girls with Turner syndrome: a randomized controlled phase 3 study.
AU  - Mauras N
AU  - Boettcher C
AU  - Højby M
AU  - Soltysik K
AU  - Jorge AAL
AU  - Kashimada K
AU  - Linglart A
AU  - Luo X
AU  - Murray PG
AU  - Backeljauw P
PY  - 2026
JO  - The Journal of clinical endocrinology and metabolism
DO  - 10.1210/clinem/dgag309
UR  - https://doi.org/10.1210/clinem/dgag309
ER  - 

APA

N, M., C, B., M, H., K, S., AAL, J., K, K., A, L., X, L., PG, M., & P, B. (2026). Once-weekly somapacitan enhances linear growth in girls with Turner syndrome: a randomized controlled phase 3 study.. The Journal of clinical endocrinology and metabolism. https://doi.org/10.1210/clinem/dgag309

Source records